Plain-English translation of NCT06959082 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , a new medication, to see if it works better when combined with the standard cancer treatment of chemotherapy and radiation therapy for head and neck cancer. Researchers want to compare two different doses of combined with chemotherapy and radiation against chemotherapy and radiation alone. The goal is to find out if this medication helps patients live longer and have better outcomes.
Head and neck cancer is a serious disease, and while chemotherapy combined with radiation therapy is the current standard treatment, doctors are looking for ways to make this treatment more effective. This trial is testing whether the medication can boost the effectiveness of standard treatment and help more patients survive and recover better.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of three groups: one group will take the lower dose of along with chemotherapy and radiation, another group will take a higher dose along with the same treatments, and a third group will receive chemotherapy and radiation without the new medication. You will take the medication by mouth and undergo standard radiation therapy over several weeks. The study will involve multiple visits to monitor your health, blood tests, and imaging scans to see how well the treatment is working and track any side effects.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
United States